[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341338-105":59,"doc-detail-341338-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","application-value-of-multi-gene-mutation-detection-in-the-clinical-management-of-pediatric-papillary-thyroid-carcinoma-a-preliminary-exploration","Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma - a preliminary exploration","","Thyroid cancer is uncommon in children and adolescents, and the clinical utility of molecular markers used in adult papillary thyroid carcinoma (PTC) for pediatric patients remains uncertain. This study retrospectively analyzed pediatric PTC cases using next-generation targeted sequencing of 116 thyroid-cancer–related genes, integrating demographic data, clinical indicators, ultrasound imaging, and pathology. Multi-gene conjoint analysis assessed correlations between molecular variations and pediatric clinical characteristics, identifying driver mutations and pediatric-specific mutation patterns that may inform diagnosis and personalized management.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/application-value-of-multi-gene-mutation-detection-in-the-clinical-management-of-pediatric-papillary-thyroid-carcinoma-a-preliminary-exploration/341338/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/application-value-of-multi-gene-mutation-detection-in-the-clinical-management-of-pediatric-papillary-thyroid-carcinoma-a-preliminary-exploration/341338.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of this study on pediatric papillary thyroid carcinoma?","Question",{"text":112,"@type":113},"To explore whether molecular markers and a multi-gene conjoint analysis using next-generation targeted sequencing have comparable utility in pediatric patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients and samples selected for mutation detection?",{"text":117,"@type":113},"Pediatric PTC patients (age 18 or younger) were retrospectively screened, and targeted enrichment sequencing was performed on paraffin-embedded tumor tissues and paired paracancerous tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genetic findings were reported as key results in pediatric PTC?",{"text":121,"@type":113},"BRAF V600E and RET fusion were detected in 73.33% of pediatric cases, and pediatric PTC showed a more complex mutation landscape with additional unique mutant genes compared with adults.",{"name":123,"@type":110,"acceptedAnswer":124},"How can multi-gene testing be used in clinical management according to the conclusion?",{"text":125,"@type":113},"For pediatric thyroid nodules that cannot be classified as benign or malignant by fine needle aspiration biopsy, multiple gene combination testing may support personalized diagnosis and treatment.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},341338,1790137290,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Original Research PUBLISHED 05 June 2024  \nDOI 10.3389/fendo.2024.1405142  \nOPEN ACCESS  \nEDITED BY  \nAntonio Balsamo,  \nUniversity Hospital S. Orsola Malpighi, Italy  \nREVIEWED BY  \nAlessandra Cassio, University of Bologna, Italy Roberto Gastaldi,  \nGiannina Gaslini Institute (IRCCS), Italy  \n*CORRESPONDENCE Xiaoqin Qian  \n[yz_tyz1030@126.com](yz_tyz1030@126.com)[ ](yz_tyz1030@126.com)Na Yan  \n[yanna@dazd.cn](yanna@dazd.cn);  \n[yanna189225@hotmail.com](yanna189225@hotmail.com)  \n†These authors have contributed equally to this work  \nRECEIVED 22 March 2024  \nACCEPTED 22 May 2024  \nPUBLISHED 05 June 2024  \nCITATION  \nWang Y, Wang H, Tan G, Wu X, Wang B, Tan Z, Du J, Li X, Xu Y, Yan N and Qian X (2024) Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.  \nFront. Endocrinol. 15:1405142 .  \ndoi: 10.3389/fendo.2024.1405142  \nCOPYRIGHT  \n© 2024 Wang, Wang, Tan, Wu, Wang, Tan, Du, Li, Xu, Yan and Qian. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nApplication value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration  \nYuguo Wang1,2,3†, Hui Wang 4†, Gongxun Tan 5†, Xinping Wu 6, Bin Wang 1, Zhihan Tan 6, Jing Du 6, Xiuying Li 7,8, Ying Xu 7,8, Na Yan 8* and Xiaoqin Qian 5*  \n1 Department of Ultrasound, Traditional Chinese Medicine Hospital of Nanjing Lishui District, Nanjing, Jiangsu, China, 2Afﬁliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China, 3Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu, China, 4 Department of Endocrinology, Yancheng City No. 6 People’s Hospital, Yancheng, Jiangsu, China, 5 Department of Ultrasound, Afﬁliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, China, 6 Department of Ultrasound, Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, Jiangsu, China, 7 Nanjing Dian Diagnostics Group Co., Ltd., Nanjing, Jiangsu, China, 8 Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang, China  \nObjectives: Thyroid cancer rarely occurs in children and adolescents. Molecular markers such as BRAF, RAS, and RET/PTC have been widely used in adult PTC. It is currently unclear whether these molecular markers have equivalent potential for application in pediatric patients. This study aims to explore the potential utility of a multi-gene conjoint analysis based on next-generation targeted sequencing for pediatric papillary thyroid carcinoma (PTC) .  \nMaterials and methods: The patients diagnosed with PTC (aged 18 years or younger) in the pediatrics department of Lishui District Hospital of Traditional Chinese Medicine were retrospectively screened. A targeted enrichment and sequencing analysis of 116 genes associated with thyroid cancer was performed on parafﬁn-embedded tumor tissues and paired paracancerous tissue of ﬁfteen children (average age 14 .60) and nine adults (average age 49 .33) PTC patients. Demographic information, clinical indicators, ultrasonic imaging information and pathological data were collected. The Kendall correlation test was used to establish a correlation between molecular variations and clinical characteristics in pediatric patients.  \nResults: A sample of 15 pediatric PTCs revealed a detection rate of 73 .33%(11/15) for driver gene mutations BRAF V600E and RET fusion. Compared to adult PTCs,","cbCaikqktjaL2IzN","https://ap.wps.com/l/cbCaikqktjaL2IzN","pdf",3121826,"English","# Objectives\n## Materials and methods\n## Results\n## Conclusion","[{\"question\":\"What was the main objective of this study on pediatric papillary thyroid carcinoma?\",\"answer\":\"To explore whether molecular markers and a multi-gene conjoint analysis using next-generation targeted sequencing have comparable utility in pediatric patients.\"},{\"question\":\"How were patients and samples selected for mutation detection?\",\"answer\":\"Pediatric PTC patients (age 18 or younger) were retrospectively screened, and targeted enrichment sequencing was performed on paraffin-embedded tumor tissues and paired paracancerous tissues.\"},{\"question\":\"Which genetic findings were reported as key results in pediatric PTC?\",\"answer\":\"BRAF V600E and RET fusion were detected in 73.33% of pediatric cases, and pediatric PTC showed a more complex mutation landscape with additional unique mutant genes compared with adults.\"},{\"question\":\"How can multi-gene testing be used in clinical management according to the conclusion?\",\"answer\":\"For pediatric thyroid nodules that cannot be classified as benign or malignant by fine needle aspiration biopsy, multiple gene combination testing may support personalized diagnosis and treatment.\"}]","Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma - a preliminary exploration | PDF",1790041589,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6af1d428c23623142c09b02fcd6247d0.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3a32a16b0b49392c5933128229f9bd2.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c23f8f0d6f8d8dcb7f9ea707fd596adc.webp",981,1386,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82c763b5cbab612907c71300993d1b3c.webp",980,1385]